Side-by-side comparison of AI visibility scores, market position, and capabilities
Comcast-owned NBCUniversal streamer with 34M+ paid subscribers; NFL games, Premier League, and Big Ten sports rights plus NBC/Bravo catalog competing in mid-tier streaming.
Peacock is NBCUniversal's streaming video service offering a combination of free ad-supported and paid subscription tiers with content from NBC, Bravo, USA Network, Syfy, E!, MSNBC, CNBC, and Universal Pictures — alongside live sports (NFL, Premier League, Big Ten football, WWE) and Peacock Original programming. Launched in April 2020 and owned by Comcast (which owns NBCUniversal), Peacock had grown to approximately 34 million paid subscribers by late 2024, making it one of the mid-tier streamers in the increasingly competitive streaming landscape.\n\nPeacock's content strategy differentiates through sports rights — particularly its exclusive streaming rights to NFL playoff games and Sunday Night Football (shared with NBC), English Premier League soccer, and Big Ten college football — and its large back catalog of NBC broadcast and cable content. The platform's hybrid model (free ad-supported Peacock Free, paid Peacock Premium) allows it to monetize both advertising-averse subscribers willing to pay and price-sensitive viewers who tolerate ads.\n\nIn 2025, Peacock continues Comcast's push to build a direct-to-consumer streaming relationship with consumers who have historically only engaged with NBC content through cable. The service faces the fundamental challenge of the streaming wars: competing against Netflix, Disney+, Max, and Amazon Prime Video for subscriber attention and spending. Peacock's advantage is its sports programming (a key streaming battleground) and Comcast's ability to bundle Peacock with Xfinity cable and internet subscriptions. The 2025 strategy focuses on live sports exclusives, expanding Peacock Originals, and leveraging Comcast distribution for subscriber growth.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.